(0.07%) 5 473.08 points
(0.10%) 39 151 points
(0.36%) 17 781 points
(-0.22%) $80.65
(-3.66%) $2.66
(-0.78%) $2 312.70
(0.20%) $28.93
(3.50%) $1 020.90
(0.28%) $0.936
(0.70%) $10.68
(0.45%) $0.792
(-0.28%) $87.25
Live Chart Being Loaded With Signals
Erasca, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers...
Stats | |
---|---|
今日成交量 | 1.01M |
平均成交量 | 1.68M |
市值 | 536.58M |
EPS | $-0.230 ( Q1 | 2024-05-08 ) |
下一个收益日期 | ( $-0.170 ) 2024-08-08 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-2.46 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.00800 (0.39%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-06-20 | Varney Michael David | Buy | 60 000 | Stock Option (right to buy) |
2024-06-20 | Start Valerie Denise Harding | Buy | 60 000 | Stock Option (right to buy) |
2024-06-20 | Liu Jean I | Buy | 60 000 | Stock Option (right to buy) |
2024-06-20 | Garner Ebun | Buy | 160 082 | Stock Option (right to buy) |
2024-06-20 | Morris Shannon | Buy | 137 142 | Stock Option (right to buy) |
INSIDER POWER |
---|
94.48 |
Last 97 transactions |
Buy: 51 526 214 | Sell: 10 940 033 |
音量 相关性
Erasca, Inc. 相关性
10 最正相关 |
---|
10 最负相关 |
---|
你知道吗?
相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。
相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。
Erasca, Inc. 相关性 - 货币/商品
Erasca, Inc. 财务报表
Annual | 2023 |
营收: | $0 |
毛利润: | $-3.73M (0.00 %) |
EPS: | $-0.830 |
FY | 2023 |
营收: | $0 |
毛利润: | $-3.73M (0.00 %) |
EPS: | $-0.830 |
FY | 2022 |
营收: | $0 |
毛利润: | $-2.64M (0.00 %) |
EPS: | $-1.950 |
FY | 2021 |
营收: | $0.00 |
毛利润: | $0.00 (0.00 %) |
EPS: | $-1.790 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Erasca, Inc.
Erasca, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company\'s lead candidates include ERAS-007, an oral inhibitor of ERK1/2 for the treatment of non-small cell lung cancer, colorectal cancer, and acute myeloid leukemia; and ERAS-601, an oral SHP2 inhibitor for patients with advanced or metastatic solid tumors. It is also developing ERAS-801, a central nervous system-penetrant EGFR inhibitor for the treatment of patients with recurrent glioblastoma multiforme. The company was incorporated in 2018 and is headquartered in San Diego, California.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。